Cheng Qu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cheng Qu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Chongyang Wang
Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
1 shared publication - Cunyi Fan
Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
1 shared publication - Dian Wang
Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Haoyuan Wang
Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Jiacheng Hu
Department of Orthopedics, Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, People’s Republic of China
1 shared publication - Jian Lu
Department of Orthopedics, Shanghai Eighth People’s Hospital, Shanghai, People’s Republic of China
1 shared publication
Latest Publications
- 3 November 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
Pharmacological Inhibition of STING with H-151 Promotes Rotator Cuff Healing in Aged Rats
Background: Although the cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes) pathway is a key driver of inflammaging in age-related musculoskeletal disorders, its role in age-related rotator cuff tears (RCTs) remains unknown. This study investigated whether inhibition of the cGAS-STING pathway with H-151 could improve tendon-to-bone healing in aged rats after rotator cuff repair (RCR). Methods: Forty-eight Sprague-Dawley rats were assigned to 4 groups: young control (sham surgery), aged control (sham surgery), aged RCT (RCR with fibrin), and aged RCT+H-151 (RCR with H-151-loaded fibrin). Rats in the RCT groups underwent bilateral RCR, after which the tendon-bone enthesis was treated with the respective fibrin gel. The status of the cGAS-STING pathway, expression of inflammaging and differentiation markers, and histological and biomechanical properties of the supraspinatus-humerus complex were evaluated. Results: The cGAS-STING pathway was markedly activated at the tendon-bone enthesis in the aged rats. Treatment with H-151 effectively suppressed its downstream effectors ( Ifnb and Cxcl10 ), reduced inflammaging markers ( Cdkn2a, Cdkn1a, Il1b, and Il6 ), and enhanced the expression of chondrogenic ( Acan and Col2a1 ) and tenogenic ( Tnmd and Scx ) differentiation markers. Histological assessment revealed improved collagen organization and enhanced cartilage regeneration at the enthesis in the aged RCT+H-151 group, which also achieved a higher histological score. Biomechanically, the aged RCT+H-151 group exhibited significantly increased failure load, stiffness, and tensile stress compared with the aged RCT group. Conclusions: The cGAS-STING pathway was activated at the tendon-bone enthesis in aged rats. The inhibition of STING with H-151 in similar rats attenuated inflammaging, promoted collagen maturation and fibrocartilage regeneration, and substantially improved the biomechanical properties of the repaired enthesis. Clinical Relevance: Inhibition of the cGAS-STING pathway using STING antagonists may be a promising therapeutic strategy for enhancing rotator cuff healing in older patients.
- 3 November 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
Pharmacological Inhibition of STING with H-151 Promotes Rotator Cuff Healing in Aged Rats
Background: Although the cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes) pathway is a key driver of inflammaging in age-related musculoskeletal disorders, its role in age-related rotator cuff tears (RCTs) remains unknown. This study investigated whether inhibition of the cGAS-STING pathway with H-151 could improve tendon-to-bone healing in aged rats after rotator cuff repair (RCR). Methods: Forty-eight Sprague-Dawley rats were assigned to 4 groups: young control (sham surgery), aged control (sham surgery), aged RCT (RCR with fibrin), and aged RCT+H-151 (RCR with H-151-loaded fibrin). Rats in the RCT groups underwent bilateral RCR, after which the tendon-bone enthesis was treated with the respective fibrin gel. The status of the cGAS-STING pathway, expression of inflammaging and differentiation markers, and histological and biomechanical properties of the supraspinatus-humerus complex were evaluated. Results: The cGAS-STING pathway was markedly activated at the tendon-bone enthesis in the aged rats. Treatment with H-151 effectively suppressed its downstream effectors ( Ifnb and Cxcl10 ), reduced inflammaging markers ( Cdkn2a, Cdkn1a, Il1b, and Il6 ), and enhanced the expression of chondrogenic ( Acan and Col2a1 ) and tenogenic ( Tnmd and Scx ) differentiation markers. Histological assessment revealed improved collagen organization and enhanced cartilage regeneration at the enthesis in the aged RCT+H-151 group, which also achieved a higher histological score. Biomechanically, the aged RCT+H-151 group exhibited significantly increased failure load, stiffness, and tensile stress compared with the aged RCT group. Conclusions: The cGAS-STING pathway was activated at the tendon-bone enthesis in aged rats. The inhibition of STING with H-151 in similar rats attenuated inflammaging, promoted collagen maturation and fibrocartilage regeneration, and substantially improved the biomechanical properties of the repaired enthesis. Clinical Relevance: Inhibition of the cGAS-STING pathway using STING antagonists may be a promising therapeutic strategy for enhancing rotator cuff healing in older patients.
- 1 January 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 54 (1) , 152-161
Alpha-Ketoglutarate, a Natural Endogenous Metabolite, Enhances Rotator Cuff Tendon–to-Bone Healing by Mitigating Postmenopausal Osteoporosis
Background: Compromised bone strength in proximal humerus osteoporosis predisposes patients with rotator cuff repair (RCR) to an increased anchor pull-out risk and healing failure. Purpose: To explore the potential of locally administered alpha-ketoglutarate (αKG), a natural metabolite in the tricarboxylic acid cycle, to enhance rotator cuff healing by mitigating osteoporosis. Study Design: Controlled laboratory study. Methods: A total of 48 female Sprague-Dawley rats were assigned into 4 groups: normal control (sham surgery), ovariectomy (OVX) control, OVX–rotator cuff tear (RCT) (RCR with fibrin application after OVX), and OVX-RCT-αKG (RCR with αKG-enriched fibrin treatment after OVX). Bilateral RCR was performed on rats in 2 RCT groups, with the respective application of fibrin or αKG-enriched fibrin gel at the tendon-bone interface (TBI). At 6 weeks and 12 weeks postoperatively, bone quality was evaluated using micro–computed tomography (CT), while histology and immunohistochemistry were used to assess bone, TBI, and tendon quality. Biomechanical tests determined the strength of the tendon-to-bone complex. Results: Micro-CT analysis confirmed proximal humerus osteoporosis after OVX. Alpha-KG–enriched fibrin leads to improved bone quality compared with OVX-RCT, more prominent at 12 weeks after surgery, as evidenced by the higher bone volume/total volume fraction, trabecular number, and trabecular thickness. Histological and immunohistochemical analyses demonstrated enhanced bone regeneration and improved TBI integrity in the OVX-RCT-αKG group, which could be explained by decreased osteoclastic and increased osteoblastic activity. Biomechanical testing showed improved tendon-bone resilience, with higher ultimate failure load and stress after αKG treatment. Conclusion: Local supplementation of αKG, a natural metabolite, along with the repair surgery could effectively improve proximal humerus osteoporosis, thereby enhancing RCR. It holds great potential for preventing anchor pullout and improving RCT outcomes in patients with osteoporosis. Clinical Relevance: Alpha-KG supplementation along with surgery may enhance RCR for patients with osteoporosis complications.
- 1 January 2026
- Published by SAGE Publications in The American Journal of Sports Medicine
- Vol. 54 (1) , 152-161
Alpha-Ketoglutarate, a Natural Endogenous Metabolite, Enhances Rotator Cuff Tendon–to-Bone Healing by Mitigating Postmenopausal Osteoporosis
Background: Compromised bone strength in proximal humerus osteoporosis predisposes patients with rotator cuff repair (RCR) to an increased anchor pull-out risk and healing failure. Purpose: To explore the potential of locally administered alpha-ketoglutarate (αKG), a natural metabolite in the tricarboxylic acid cycle, to enhance rotator cuff healing by mitigating osteoporosis. Study Design: Controlled laboratory study. Methods: A total of 48 female Sprague-Dawley rats were assigned into 4 groups: normal control (sham surgery), ovariectomy (OVX) control, OVX–rotator cuff tear (RCT) (RCR with fibrin application after OVX), and OVX-RCT-αKG (RCR with αKG-enriched fibrin treatment after OVX). Bilateral RCR was performed on rats in 2 RCT groups, with the respective application of fibrin or αKG-enriched fibrin gel at the tendon-bone interface (TBI). At 6 weeks and 12 weeks postoperatively, bone quality was evaluated using micro–computed tomography (CT), while histology and immunohistochemistry were used to assess bone, TBI, and tendon quality. Biomechanical tests determined the strength of the tendon-to-bone complex. Results: Micro-CT analysis confirmed proximal humerus osteoporosis after OVX. Alpha-KG–enriched fibrin leads to improved bone quality compared with OVX-RCT, more prominent at 12 weeks after surgery, as evidenced by the higher bone volume/total volume fraction, trabecular number, and trabecular thickness. Histological and immunohistochemical analyses demonstrated enhanced bone regeneration and improved TBI integrity in the OVX-RCT-αKG group, which could be explained by decreased osteoclastic and increased osteoblastic activity. Biomechanical testing showed improved tendon-bone resilience, with higher ultimate failure load and stress after αKG treatment. Conclusion: Local supplementation of αKG, a natural metabolite, along with the repair surgery could effectively improve proximal humerus osteoporosis, thereby enhancing RCR. It holds great potential for preventing anchor pullout and improving RCT outcomes in patients with osteoporosis. Clinical Relevance: Alpha-KG supplementation along with surgery may enhance RCR for patients with osteoporosis complications.